FDA panel recommends Claritin as OTC drug. (Urticaria Indication Debated).: An article from: Skin & Allergy News

This digital document is an article from Skin & Allergy News, published by International Medical News Group on June 1, 2002. The length of the article is 653 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: FDA panel recommends Claritin as OTC drug. (Urticaria Indication Debated).
Author: Deeanna Franklin
Publication:Skin & Allergy News (Magazine/Journal)
Date: June 1, 2002
Publisher: International Medical News Group
Volume: 33 Issue: 6 Page: 30(1)

Distributed by Thomson Gale